SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
203 hedge funds and large institutions have $1.1B invested in Sage Therapeutics in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 200 → 203 (+3)
11% less capital invested
Capital invested by funds: $1.23B → $1.1B (-$138M)
Holders
203
Holding in Top 10
–
Calls
$5.76M
Puts
$3.67M
Top Buyers
| 1 | +$17.8M | |
| 2 | +$12M | |
| 3 | +$10.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.1M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$7.63M |
Top Sellers
| 1 | -$24.5M | |
| 2 | -$17M | |
| 3 | -$9.67M | |
| 4 |
Morgan Stanley
New York
|
-$9.08M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$5.31M |